LeonaBio (LONA) Assets Average (2020 - 2026)

LeonaBio (LONA) has 7 years of Assets Average data on file, last reported at $81.9 million in Q1 2026.

• Quarterly Assets Average rose 60.07% year-over-year to $81.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $81.9 million (up 60.07% YoY) and the FY2025 annual result came in at $75.5 million, down 31.09% from the prior year.
• Assets Average advanced to $81.9 million in Q1 2026 per LONA's latest filing, from $61.1 million in the prior quarter.
• Across five years, Assets Average topped out at $322.5 million in Q1 2022 and bottomed at $32.8 million in Q3 2025.
• The 5-year median for Assets Average is $146.9 million (2024), against an average of $159.8 million.
• The widest annual swing landed in 2025, when Assets Average plunged 67.69%; it then surged 60.07% in 2026.
• Tracing LONA's Assets Average over 5 years: stood at $266.2 million in 2022, then tumbled by 35.2% to $172.5 million in 2023, then sank by 57.96% to $72.5 million in 2024, then slipped by 15.75% to $61.1 million in 2025, then surged by 34.01% to $81.9 million in 2026.
• Per Business Quant, the three latest LONA Assets Average figures stand at $81.9 million (Q1 2026), $61.1 million (Q4 2025), and $32.8 million (Q3 2025).

Peer Comparison